SARS-CoV-2 infection in patients with primary central nervous system lymphoma

BACKGROUND: Cancer patients may be at higher risk for severe coronavirus infectious disease-19 (COVID-19); however, the outcome of Primary Central Nervous System Lymphoma (PCNSL) patients with SARS-CoV-2 infection has not been described yet. METHODS: We conducted a retrospective study within the Lym...

Descripción completa

Detalles Bibliográficos
Autores principales: Laurenge, Alice, Ursu, Renata, Houillier, Caroline, Abdi, Basma, Tebano, Gianpiero, Quemeneur, Cyril, Choquet, Sylvain, Di Blasi, Roberta, Lozano, Fernando, Morales, Andrea, Durán-Peña, Alberto, Sirven-Villaros, Lila, Mathon, Bertrand, Mokhtari, Karima, Bielle, Franck, Martin-Duverneuil, Nadine, Delattre, Jean-Yves, Marcelin, Anne-Geneviève, Pourcher, Valérie, Alentorn, Agusti, Idbaih, Ahmed, Carpentier, Antoine F., Leblond, Véronique, Hoang-Xuan, Khê, Touat, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776286/
https://www.ncbi.nlm.nih.gov/pubmed/33387015
http://dx.doi.org/10.1007/s00415-020-10311-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776286/
https://www.ncbi.nlm.nih.gov/pubmed/33387015
http://dx.doi.org/10.1007/s00415-020-10311-w

Ejemplares similares